未登录

Y

Yuki Niwa

University of Osaka

H指数:22

被引数:1,637

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Use of tight junction binders to analyze the barrier function of human placental JEG-3 cells

使用紧密连接结合剂分析人胎盘JEG-3细胞的屏障功能

IF2.5

2026-08-010

PRE

Overview of the Japanese Rapid Introduction Premium as a drug pricing framework to enhance patient access to innovative drugs

日本快速引进附加费的药物定价框架概述：用于提高患者对创新药物的获取能力

Health Economics Review

IF3.3

2025-11-270

OAAI

Identification of amino acids essential for angulin-1/3 binding of the tricellular tight junction binder, angubindin-1

鉴定对三细胞紧密连接结合蛋白angubindin-1与angulin-1/3结合至关重要的氨基酸

IF2.3

2025-09-100

OAAI

An in vitro safety evaluation model for assessing the effects of a chemical drug on the human intestinal barrier integrity using genetically modified Caco-2 cells expressing drug-metabolizing enzymes

一种用于评估化学药物对人类肠屏障完整性影响的体外安全性评价模型，该模型使用表达药物代谢酶的基因修饰Caco-2细胞。

Toxicology Letters

IF2.9

2025-07-010

PRE

Size-selective permeation-enhancing modulation of the tight junction by receptor-binding domains of Clostridium perfringens enterotoxin and Clostridium perfringens iota-toxin

TISSUE BARRIERS

IF4

2025-02-050

PRE

Safety and Effectiveness of Four-Factor Prothrombin Complex Concentrate in Special Populations with INR Below 2: A Post-Marketing Surveillance Study

CARDIOLOGY AND THERAPY

IF2.7

2024-08-030

OAAI

Combination activity of eribulin liposomal formulation and anti-PD-1 antibody after tumor regrowth during anti-PD-1 antibody treatment in mice

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Real-World Safety and Effectiveness of a 4-Factor Prothrombin Complex Concentrate in Japanese Patients Experiencing Major Bleeding: A Post-marketing Surveillance Study

CARDIOLOGY AND THERAPY

IF2.7

2024-02-061

OAAI

Biogenesis of fibrils requires C-mannosylation of PMEL

IF4.2

2023-08-182

OA

Antitumor activity of liposomal formulation of eribulin combined with anti-human PD-1 antibody using hPBMC-humanized mouse models

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Anti-tumor activity of a liposomal formulation of Eribulin compared with the same dose of Eribulin in patient-derived breast cancer xenografts

CANCER RESEARCH

IF16.6

2023-03-010

PRE

Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti-PD-1 Antibody

MOLECULAR CANCER THERAPEUTICS

IF5.5

2023-01-2410

OAAI

Identification of topoisomerases as molecular targets of cytosporolide C and its analog

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2019-08-017

PREAI

Identification and characterization of collagen-like glycosylation and hydroxylation of CCN1

CCN1的胶原蛋白样糖基化和羟基化的鉴定和表征

IF3.3

2019-07-185

PREAI

Stable Iron Porphyrin Intramolecularly Coordinated by Alcoholate Anion: Synthesis and Evaluation of Axial Ligand Effect of Alcoholate on Spectroscopy and Catalytic Activity

INORGANIC CHEMISTRY

IF4.7

2019-03-212

PREAI

Topological analysis of DPY19L3, a human C-mannosyltransferase

IF4.2

2018-02-1611

OAAI

Integrin β1 plays a crucial role in vasculogenic mimicry formation

MOLECULAR CANCER THERAPEUTICS

IF5.5

2018-01-010

PRE

Neoechinulin A induced memory improvements and antidepressant-like effects in mice

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2016-11-0115

PREAI

C-mannosylation of R-spondin3 regulates its secretion and activity of Wnt/β-catenin signaling in cells

IF3

2016-07-1335

OAAI

Identification of DPY19L3 as the C-mannosyltransferase of R-spondin1 in human cells

MOLECULAR BIOLOGY OF THE CELL

IF2.7

2016-03-0147

OAAI